SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
INTERMUNE
(NQNM:ITMN Last Sale: 15.09 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (ITMN : $15.09)
$695 million Market Cap at September 12, 2013
Biomedics SubIndustry up .00% / Health Industry up .00% Today
3280 Bayshore Boulevard Research Report Earnings Snapshot - Last 08/06/18
Brisbane, CA 94005 Fact Sheet
Phone: (415) 466-2200 Financial Statements
Peer Comparison
Annual Reports

Daniel G. Welch, Pres./CEO, Sharon Surrey-Barbari, CFO
Formerly INTERMUNE PHARMACEUTICALS INC (NASDAQ:ITMN) Markets drugs for the treatment of immune system diseases. Is also developing applications for osteopetrosis, idiopathic pulmonary fibrosis, systemic fungal infections, and cystic fibrosis. IPO at $20 March 23, 2000. Raised $125 million, selling 6.3 million shares, 31% of the outstanding. Lead Manager: Warburg Dillon Read LLC.
Historical Charts    Technical Analysis
No Historical Data available for ITMN

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ITMN $15.09 $ 0 $14.79 $15.25 860,566 $7.8 $16 46,069
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $695,181

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex